References
- Abdel-Rahman, E.M., et al., 2012. Therapeutic modalities in diabetic nephropathy: standard and emerging approaches. Journal of general internal medicine, 27 (4), 458–468.
- Brown, C.J., et al., 1991. A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome. Nature, 349 (6304), 38–44.
- Dalla Vestra, M., et al., 2005. Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. Journal of the American society of nephrology, 16 (3 Suppl 1), S78–S82.
- Fioretto, P. and Mauer, M., 2010. Diabetic nephropathy: diabetic nephropathy-challenges in pathologic classification. Nature reviews. Nephrology, 6 (9), 508–510.
- Gao, J., et al., 2018. LncRNA-NR_033515 promotes proliferation, fibrogenesis and epithelial-to-mesenchymal transition by targeting miR-743b-5p in diabetic nephropathy. Biomedicine & pharmacotherapy, 106, 543–552.
- Ge, Y., et al., 2019. lncRNA NR_038323 suppresses renal fibrosis in diabetic nephropathy by targeting the miR-324-3p/DUSP1 axis. Molecular therapy. Nucleic acids, 17, 741–753.
- Geisler, S. and Coller, J., 2013. RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nature reviews. Molecular cell biology, 14 (11), 699–712.
- He, L. and Hannon, G.J., 2004. MicroRNAs: small RNAs with a big role in gene regulation. Nature reviews. Genetics, 5 (7), 522–531.
- Jin, L.W., et al., 2019. Down-regulation of the long non-coding RNA XIST ameliorates podocyte apoptosis in membranous nephropathy via the miR-217-TLR4 pathway. Experimental physiology, 104 (2), 220–230.
- Koerner, J., Brunner, T., and Groettrup, M., 2017. Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice. Oncotarget, 8 (31), 50873–50888.
- Li, Z.Y., et al., 2017. Brazilin ameliorates diabetic nephropathy and inflammation in db/db mice. Inflammation, 40 (4), 1365–1374.
- Matoba, K., et al., 2019. Unraveling the role of inflammation in the pathogenesis of diabetic kidney disease. International journal of molecular sciences, 20 (14), 3393.
- Mattick, J.S. and Rinn, J.L., 2015. Discovery and annotation of long noncoding RNAs. Nature structural & molecular biology, 22 (1), 5–7.
- Mercer, T.R., Dinger, M.E., and Mattick, J.S., 2009. Long non-coding RNAs: insights into functions. Nature reviews. Genetics, 10 (3), 155–159.
- Navarro, J.F. and Mora, C., 2006. Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy. The scientific world journal, 6, 908–917.
- Navarro-Gonzalez, J.F., et al., 2011. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nature reviews. Nephrology, 7 (6), 327–340.
- Peng, W., et al., 2019. Long noncoding RNA NONHSAG053901 promotes diabetic nephropathy via stimulating Egr-1/TGF-β-mediated renal inflammation. Journal of cellular physiology, 234 (10), 18492–18503.
- Saran, R., et al., 2017. US renal data system 2016 annual data report: epidemiology of kidney disease in the United States. American journal of kidney diseases: the official journal of the national kidney foundation, 69 (3 Suppl 1), A7–A8.
- Shikata, K. and Makino, H., 2013. Microinflammation in the pathogenesis of diabetic nephropathy. Journal of diabetes investigation, 4 (2), 142–149.
- Sun, N., Zhang, G., and Liu, Y., 2018. Long non-coding RNA XIST sponges miR-34a to promotes colon cancer progression via Wnt/β-catenin signaling pathway. Gene, 665, 141–148.
- Tang, Y., et al., 2017. lncRNA XIST interacts with miR-140 to modulate lung cancer growth by targeting iASPP. Oncology reports, 38 (2), 941–948.
- Tay, Y., Rinn, J., and Pandolfi, P.P., 2014. The multilayered complexity of ceRNA crosstalk and competition. Nature, 505 (7483), 344–352.
- Tervaert, T.W., et al., 2010. Pathologic classification of diabetic nephropathy. Journal of the American society of nephrology, 21 (4), 556–563.
- Wang, K.C. and Chang, H.Y., 2011. Molecular mechanisms of long noncoding RNAs. Molecular cell, 43 (6), 904–914.
- Watkins, P.J., 1985. Diabetic nephropathy-prevalence, complications and treatment. Diabetic medicine: a journal of the British diabetic association, 2 (1), 7–12.
- Wei, W., et al., 2017. LncRNA XIST promotes pancreatic cancer proliferation through miR-133a/EGFR. Journal of cellular biochemistry, 118 (10), 3349–3358.
- Wu, J., et al., 2020. miR-485 suppresses inflammation and proliferation of mesangial cells in an in vitro model of diabetic nephropathy by targeting NOX5. Biochemical and biophysical research communications, 521 (4), 984–990.
- Xu, G., et al., 2019. The miR-15a-5p-XIST-CUL3 regulatory axis is important for sepsis-induced acute kidney injury. Renal failure, 41 (1), 955–966.
- Yamagishi, S., 2011. Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes. Experimental gerontology, 46 (4), 217–224.
- Yi, H., et al., 2017. LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy. Cell death & disease, 8 (2), e2583.
- Zhang, J., et al., 2019a. lncRNA MALAT1 mediated high glucose-induced HK-2 cell epithelial-to-mesenchymal transition and injury. Journal of physiology and biochemistry, 75 (4), 443–452.
- Zhang, P., et al., 2019b. Long non-coding RNA Rpph1 promotes inflammation and proliferation of mesangial cells in diabetic nephropathy via an interaction with Gal-3. Cell death and disease, 10 (7), 526